JP2012249597A - Method for producing phospholipid - Google Patents

Method for producing phospholipid Download PDF

Info

Publication number
JP2012249597A
JP2012249597A JP2011125743A JP2011125743A JP2012249597A JP 2012249597 A JP2012249597 A JP 2012249597A JP 2011125743 A JP2011125743 A JP 2011125743A JP 2011125743 A JP2011125743 A JP 2011125743A JP 2012249597 A JP2012249597 A JP 2012249597A
Authority
JP
Japan
Prior art keywords
phospholipid
phospholipase
activity
less
units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011125743A
Other languages
Japanese (ja)
Other versions
JP5894377B2 (en
Inventor
Tateshi Tanaka
立志 田中
Masayuki Murayama
誠之 村山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Priority to JP2011125743A priority Critical patent/JP5894377B2/en
Publication of JP2012249597A publication Critical patent/JP2012249597A/en
Application granted granted Critical
Publication of JP5894377B2 publication Critical patent/JP5894377B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a stable phospholipid of which hydrolysis is suppressed by deactivating remaining PLA2 (phospholipase A2) in a reaction solution in the production of the phospholipid by using the PLA2, and to provide a method for producing the phospholipid inexpensively.SOLUTION: The method for producing the phospholipid having a remaining phospholipase A2 activity of ≤10 units/g includes adding a glycerol solution of inorganic salts, a ≤4C alcohol, and an organic solvent immiscible with the glycerol and dissolving the phospholipid to the phospholipid obtained by an esterification reaction of a fatty acid with a lysophospholipid by the phospholipase A2, standing still the resultant product after being sufficiently stirred, and extracting the organic solvent layer.

Description

本発明は、食用や飼料用に適したリン脂質及びその製造方法に関する。   The present invention relates to a phospholipid suitable for food and feed and a method for producing the same.

近年の脂質に関する研究から、ドコサヘキサエン酸(DHA)、エイコサペンタエン酸(EPA)などの高度不飽和脂肪酸が学習機能向上、動脈硬化性予防、脂質代謝改善機能など様々な機能を持つことが明らかになっている。特にDHAは、ホスファチジルコリンのようなリン脂質に結合した形態で摂取することにより、トリグリセリド型と比較して抗酸化性が強く安定性が高まり、また吸収が良いためDHAの持つ生理活性が発現しやすいことが明らかになっている。DHA以外のEPAや共役リノール酸、アラキドン酸などの機能性脂肪酸においてもリン脂質に結合することで生理活性が高まることが期待できる。   Recent research on lipids revealed that highly unsaturated fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) have various functions such as improved learning function, prevention of arteriosclerosis, and lipid metabolism improvement function. ing. In particular, when DHA is ingested in a form bound to a phospholipid such as phosphatidylcholine, it has a strong anti-oxidation property and stability as compared with the triglyceride type, and because it absorbs well, the physiological activity of DHA is easily expressed. It has become clear. EPA other than DHA and functional fatty acids such as conjugated linoleic acid and arachidonic acid can also be expected to increase physiological activity by binding to phospholipids.

そこで、種々の機能性の脂肪酸が結合したリン脂質の製造方法が開示されてきたが、中でも原料が安価で供給が安定な、食用として用い得る原料のみを使用し、高い反応率でリン脂質の2位に脂肪酸を導入できる方法、とりわけDHAのような高度不飽和脂肪酸を2位に導入したリン脂質及びその製法が特許文献1に開示されている。さらに、炭素数4以下のアルコールを添加してから、炭化水素溶剤及び/又はケトン溶剤及び/又はエステル溶剤からなる溶剤を加えて、グリセリン溶液層と溶剤層を形成させ、リン脂質と脂肪酸が移行した溶剤層を分離(分取)し、溶剤、もしくはシリカゲルで精製することにより目的のリン脂質が得られる旨が記載されている。   Therefore, a method for producing phospholipids having various functional fatty acids bound thereto has been disclosed. Above all, only raw materials that are inexpensive and stable in supply, and that can be used for food, are used, and phospholipids are produced with a high reaction rate. Patent Document 1 discloses a method capable of introducing a fatty acid at the 2-position, particularly a phospholipid in which a highly unsaturated fatty acid such as DHA is introduced at the 2-position, and a method for producing the same. Furthermore, after adding an alcohol having 4 or less carbon atoms, a solvent comprising a hydrocarbon solvent and / or a ketone solvent and / or an ester solvent is added to form a glycerin solution layer and a solvent layer, and phospholipids and fatty acids migrate. It is described that the target phospholipid can be obtained by separating (sorting) the solvent layer and purifying with a solvent or silica gel.

しかし、リン脂質の加水分解反応と比較して、リン脂質のエステル合成反応には多量の酵素が必要となるため、大量のホスホリパーゼA2(以下、PLA2ともいう)が残存し、そのためアレルギーなどの問題が起こる可能性があり、また経時的にリン脂質の2位が加水分解する可能性がある。   However, compared to the phospholipid hydrolysis reaction, since a large amount of enzyme is required for the ester synthesis reaction of phospholipid, a large amount of phospholipase A2 (hereinafter also referred to as PLA2) remains, which causes problems such as allergies. May occur, and the phospholipid position 2 may hydrolyze over time.

一方、アレルギー問題などのために、PLA2を用いた反応により得られたリゾリン脂質溶液中の残存PLA2を失活させる技術がいくつか開示されている。例えば特許文献2の実施例では中性プロテアーゼのみで処理しており、特許文献3では清水中70℃以上で加熱処理しており、特許文献4の実施例では中性プロテアーゼのみで処理してから蛋白除去工程を通しているが、PLA2を用いた反応により得られたリン脂質溶液系でそれらの処理を行うと、何れの系でもPLA2の量は減るものの、加熱により高度不飽和脂肪酸が劣化するか、或いは処理の最中に残存PLA2によりリン脂質の2位の脂肪酸が加水分解してしまう。   On the other hand, several techniques for inactivating residual PLA2 in a lysophospholipid solution obtained by a reaction using PLA2 due to allergy problems and the like have been disclosed. For example, in the example of patent document 2, it processed only with neutral protease, in patent document 3, it heat-processed at 70 degreeC or more of fresh water, and after processing with neutral protease only in the example of patent document 4 Through the protein removal process, if these treatments are performed in the phospholipid solution system obtained by the reaction using PLA2, the amount of PLA2 is reduced in any system, but the highly unsaturated fatty acid is deteriorated by heating, Alternatively, the fatty acid at the 2-position of the phospholipid is hydrolyzed by the residual PLA2 during the treatment.

また特許文献5では、PLA2を用いた反応により得られたリゾリン脂質溶液を、エタノールやヘキサンを一例とする溶剤と水との混合液及び無機塩類アセトン溶液とで処理することが開示されているが、系中に水分があるためにPLA2の除去は十分では無かった。   Patent Document 5 discloses that a lysophospholipid solution obtained by a reaction using PLA2 is treated with a mixed solution of a solvent and water, for example, ethanol or hexane, and an inorganic salt acetone solution. The PLA2 was not sufficiently removed due to the presence of moisture in the system.

特開2010−68799号公報JP 2010-68799 A 特開昭63−233750号公報JP-A 63-233750 特開2002−165580号公報JP 2002-165580 A 特開2003−93086号公報JP 2003-93086 A 国際公開第05/090587号International Publication No. 05/090587

本発明の目的は、PLA2を用いたリン脂質の製造において、反応溶液中の残存PLA2を失活させ、リン脂質の加水分解を抑制された安定なリン脂質及び該リン脂質を安価に製造する方法を提供することである。   An object of the present invention is to produce a stable phospholipid in which hydrolysis of the phospholipid is suppressed by inexpensively producing the phospholipid by inactivating the residual PLA2 in the reaction solution in the production of the phospholipid using PLA2. Is to provide.

本発明者らは上記課題を解決するために鋭意研究を重ねた結果、ホスホリパーゼA2による脂肪酸とリゾリン脂質の反応により得られるリン脂質反応液に、炭素数4以下のアルコール、無機塩類グリセリン溶液及び炭素数が5〜8の炭化水素溶剤を添加し、充分に撹拌した後静置し、炭化水素溶剤層を抽出するか、或いは酸性プロテアーゼで処理すれば、ホスホリパーゼA2活性が10ユニット/g以下になることを見出し、本発明を完成するに至った。   As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that a phospholipid reaction solution obtained by a reaction between a fatty acid and lysophospholipid by phospholipase A2 contains an alcohol having 4 or less carbon atoms, an inorganic salt glycerin solution, and carbon. Add 5-5 hydrocarbon solvent, stir well and let stand, extract hydrocarbon solvent layer or treat with acidic protease, phospholipase A2 activity will be 10 units / g or less As a result, the present invention has been completed.

即ち、本発明の第一は、ホスホリパーゼA2による脂肪酸とリゾリン脂質のエステル化反応により得られるリン脂質であり、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質に関する。好ましい実施態様は、残存するホスホリパーゼA2活性が5ユニット/g以下である上記記載のリン脂質に関する。より好ましくは、リン脂質の構成脂肪酸全体中、二重結合を4つ以上持つ脂肪酸及び共役した2つ以上の二重結合を持つ脂肪酸の合計量が、15重量%以上である上記記載のリン脂質に関する。   That is, the first of the present invention relates to a phospholipid obtained by an esterification reaction of a fatty acid and lysophospholipid with phospholipase A2, and the remaining phospholipase A2 activity is 10 units / g or less. A preferred embodiment relates to a phospholipid as described above, wherein the remaining phospholipase A2 activity is 5 units / g or less. More preferably, the total amount of fatty acids having 4 or more double bonds and fatty acids having 2 or more conjugated double bonds in the total constituent fatty acids of the phospholipid is 15% by weight or more. About.

本発明の第二は、(1)ホスホリパーゼA2による脂肪酸とリゾリン脂質のエステル化反応により得られるリン脂質に、無機塩類のグリセリン溶液及び炭素数4以下のアルコール、さらにはグリセリンと混和せずリン脂質を溶解する有機溶剤を添加し、充分に撹拌した後静置し、該有機溶剤層を抽出することを特徴とする、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法に関する。好ましい実施態様は、(2)無機塩類のグリセリン混合溶液中の水分量が10重量%以下である、上記記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法に関する。より好ましくは、(3)グリセリンと混和せずリン脂質を溶解する有機溶剤が、炭素数が5〜8の炭化水素溶剤及び/又はエーテル類である、上記記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法、(4)グリセリン溶液中の塩濃度が、0.2〜40重量%である上記記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法、(5)無機塩類が、硫酸亜鉛、塩化カリウム、塩化マグネシウム、硫酸マグネシウム、塩化ナトリウム及び塩化カルシウムの群より選ばれる少なくとも1種である、上記記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法、(6)炭化水素溶剤がヘキサンである、上記記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法、(7)炭素数4以下のアルコールがエタノールである上記記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法、(8)撹拌中の温度が40〜60℃である、上記記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法に関する。   The second aspect of the present invention is (1) a phospholipid obtained by esterification of a fatty acid and lysophospholipid with phospholipase A2, a glycerin solution of inorganic salts and an alcohol having 4 or less carbon atoms, and further phospholipid not miscible with glycerin. The present invention relates to a method for producing a phospholipid having a residual phospholipase A2 activity of 10 units / g or less, characterized in that an organic solvent that dissolves the phospholipase A2 is added and the mixture is sufficiently stirred and allowed to stand to extract the organic solvent layer. . A preferred embodiment relates to (2) a method for producing a phospholipid having a residual phospholipase A2 activity of 10 units / g or less, wherein the amount of water in the glycerol mixed solution of inorganic salts is 10% by weight or less. More preferably, (3) the remaining phospholipase A2 activity is 10 wherein the organic solvent that is immiscible with glycerin and dissolves the phospholipid is a hydrocarbon solvent and / or ether having 5 to 8 carbon atoms. A method for producing a phospholipid having a unit / g or less, (4) a phosphorus having a residual phospholipase A2 activity of 10 units / g or less, wherein the salt concentration in the glycerol solution is 0.2 to 40% by weight (5) The remaining phospholipase A2 activity as described above, wherein the inorganic salt is at least one selected from the group consisting of zinc sulfate, potassium chloride, magnesium chloride, magnesium sulfate, sodium chloride and calcium chloride. A method for producing a phospholipid of 10 units / g or less, (6) the remaining phospho, as described above, wherein the hydrocarbon solvent is hexane A method for producing a phospholipid having a ase A2 activity of 10 units / g or less, (7) a phospholipid having a residual phospholipase A2 activity of 10 units / g or less, wherein the alcohol having 4 or less carbon atoms is ethanol; (8) The method for producing a phospholipid according to the above, wherein the temperature during stirring is 40 to 60 ° C. and the remaining phospholipase A2 activity is 10 units / g or less.

本発明の第三は、ホスホリパーゼA2による脂肪酸とリゾリン脂質のエステル化反応により得られるリン脂質反応液を、酸性プロテアーゼで処理することを特徴とする、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法に関する。好ましい実施態様は、酸性プロテアーゼで処理した後、さらに中性プロテアーゼで処理することを特徴とする上記記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法に関する。   In the third aspect of the present invention, the remaining phospholipase A2 activity is 10 units / g or less, characterized in that a phospholipid reaction solution obtained by esterification of a fatty acid and lysophospholipid with phospholipase A2 is treated with an acidic protease. The present invention relates to a method for producing a phospholipid. A preferred embodiment relates to the above-mentioned method for producing a phospholipid having a residual phospholipase A2 activity of 10 units / g or less, characterized by treatment with an acidic protease followed by further treatment with a neutral protease.

本発明に従えば、PLA2を用いたリン脂質の製造において、反応溶液中の残存PLA2を失活させ、リン脂質の加水分解を抑制された安定なリン脂質及び該リン脂質を安価に製造する方法を提供することができる。   According to the present invention, in the production of phospholipids using PLA2, a stable phospholipid in which the remaining PLA2 in the reaction solution is deactivated and hydrolysis of the phospholipid is suppressed, and a method for producing the phospholipid at a low cost. Can be provided.

以下、本発明につき、さらに詳細に説明する。本発明のリン脂質は、ホスホリパーゼA2による脂肪酸とリゾリン脂質の反応により得られるリン脂質であって、該リン脂質中に残存するホスホリパーゼA2活性が10ユニット/g以下であることを特徴とする。該リン脂質中に残存するホスホリパーゼA2は少ない程良いが、5ユニット/g以下が好ましく、1ユニット/g以下がより好ましい。   Hereinafter, the present invention will be described in more detail. The phospholipid of the present invention is a phospholipid obtained by a reaction between a fatty acid and lysophospholipid by phospholipase A2, and is characterized in that the phospholipase A2 activity remaining in the phospholipid is 10 units / g or less. The smaller the amount of phospholipase A2 remaining in the phospholipid, the better. However, it is preferably 5 units / g or less, more preferably 1 unit / g or less.

そして、本発明のリン脂質の構成脂肪酸全体中、二重結合を4つ以上持つ脂肪酸及び共役した2つ以上の二重結合を持つ脂肪酸の合計量は、学習機能向上、動脈硬化性予防、脂質代謝改善機能など様々な機能をより強く発現するには多いほど好ましいが、15重量%以上であることがより好ましい。ここで二重結合を4つ以上持つ脂肪酸としてはDHA、EPA、アラキドン酸(ARA)などが挙げられ、共役した2つ以上の二重結合を持つ脂肪酸としては共役リノール酸、共役リノレン酸などが挙げられる。   The total amount of fatty acids having 4 or more double bonds and conjugated fatty acids having 2 or more double bonds in the total constituent fatty acids of the phospholipid of the present invention is improved learning function, prevention of arteriosclerosis, lipid It is more preferable to increase the expression of various functions such as a function of improving metabolism, but it is more preferably 15% by weight or more. Examples of fatty acids having four or more double bonds include DHA, EPA, and arachidonic acid (ARA). Examples of fatty acids having two or more conjugated double bonds include conjugated linoleic acid and conjugated linolenic acid. Can be mentioned.

リン脂質1グラム中に残存するホスホリパーゼA2活性は、大豆レシチンを基質として測定することができる。測定は大豆レシチンを分散させた水溶液に対してPLA2を含む溶液を加えて、一定のpH(例えば8.0)を維持するために1分当たりどれだけの水酸化ナトリウム水溶液を要するかで測定することができる。その際、あらかじめ酵素標準溶液で作成した検量線を用いてリン脂質に残存するPLA2活性を算出する。   The phospholipase A2 activity remaining in 1 gram of phospholipid can be measured using soybean lecithin as a substrate. Measurement is performed by adding a solution containing PLA2 to an aqueous solution in which soybean lecithin is dispersed, and measuring how much sodium hydroxide aqueous solution is required per minute in order to maintain a constant pH (for example, 8.0). be able to. At that time, the PLA2 activity remaining in the phospholipid is calculated using a calibration curve prepared in advance with an enzyme standard solution.

本発明におけるリゾリン脂質は、リン脂質から2位の脂肪酸を除いたものを指し、リン脂質とは異なる脂質を意味する。本発明に用いるリゾリン脂質は、リン脂質を改質したものを用いることができ、入手のし易さからは大豆由来や菜種由来、卵黄由来のものが好ましく、価格面からは大豆由来のものがより好ましいが、その他の植物由来のリゾリン脂質も用いることができる。   The lysophospholipid in the present invention refers to a phospholipid obtained by removing the fatty acid at the 2-position, and means a lipid different from the phospholipid. As the lysophospholipid used in the present invention, a modified phospholipid can be used. From the viewpoint of availability, those derived from soybeans, rapeseed, and egg yolk are preferable, and those derived from soybeans from the price aspect. More preferably, other plant-derived lysophospholipids can also be used.

リン脂質を改質してその2位の脂肪酸を除く方法としては、有害な物質を使用しない限り特に限定はないが、例えばホスホリパーゼA2などを用いてリン脂質の2位の脂肪酸を加水分解する方法などが挙げられる。この場合に用いることができるリン脂質は、グリセリン骨格とリン酸基及び2つの脂肪酸エステルを持つ分子で、ホスホリパーゼA2の基質になり得るものであり、スフィンゴシン骨格を持つものは含まれない。具体的には、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリンなどが例示できる。   The method of modifying the phospholipid to remove the fatty acid at the 2-position is not particularly limited as long as no harmful substance is used. For example, a method of hydrolyzing the fatty acid at the 2-position of phospholipid using phospholipase A2 or the like Etc. The phospholipid that can be used in this case is a molecule having a glycerin skeleton, a phosphate group, and two fatty acid esters, which can be a substrate for phospholipase A2, and does not include those having a sphingosine skeleton. Specific examples include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and the like.

本発明の脂肪酸とリゾリン脂質のエステル化反応において、リゾリン脂質の2位に導入する脂肪酸としては特に限定はないが、昨今の消費者の健康志向から、生理活性を高められる脂肪酸が好ましく、二重結合を4つ以上持つ脂肪酸及び共役した2つ以上の二重結合を持つ脂肪酸が例示でき、具体的には共役リノール酸、アラキドン酸、ドコサヘキサエン酸(DHA)、エイコサペンタエン酸(EPA)などの高度不飽和脂肪酸が例示できる。前記DHAやEPAは、主に海産動物油や藻類から得られる油脂を加水分解し遊離脂肪酸の形態にしたものを用いることができる。   In the esterification reaction between the fatty acid and lysophospholipid of the present invention, the fatty acid to be introduced at the 2-position of the lysophospholipid is not particularly limited. However, fatty acids that can increase physiological activity are preferable from the viewpoint of health of consumers today. Examples include fatty acids having four or more bonds and fatty acids having two or more conjugated double bonds, and specifically, advanced conjugated linoleic acid, arachidonic acid, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), etc. An unsaturated fatty acid can be illustrated. As the DHA and EPA, those obtained by hydrolyzing fats and oils obtained mainly from marine animal oils and algae to form free fatty acids can be used.

尚、本発明で高度不飽和脂肪酸とは、炭素−炭素間の2重結合の数が3つ以上の不飽和脂肪酸、又は共役リノール酸を意味するものとする。   In the present invention, the highly unsaturated fatty acid means an unsaturated fatty acid having 3 or more carbon-carbon double bonds or conjugated linoleic acid.

また、DHAなどのように、天然由来のものを単体で入手することが困難である場合は、所望の脂肪酸を含有する脂肪酸の混合物を用いることができる。その際、脂肪酸混合物中の所望の脂肪酸の含有量は、概ね20重量%以上であることが望ましい。DHAの場合を例示すると、DHA含有脂肪酸中のDHAの濃度は好ましくは20重量%以上であり、45重量%以上がより好ましい。尚、本発明による反応の後に溶剤分別などを行い、反応生成物であるリン脂質の濃度を高めても構わない。   In addition, when it is difficult to obtain a naturally derived material alone, such as DHA, a mixture of fatty acids containing a desired fatty acid can be used. At that time, the content of the desired fatty acid in the fatty acid mixture is desirably approximately 20% by weight or more. In the case of DHA, the concentration of DHA in the DHA-containing fatty acid is preferably 20% by weight or more, and more preferably 45% by weight or more. In addition, solvent fractionation etc. may be performed after reaction by this invention, and the density | concentration of the phospholipid which is a reaction product may be raised.

本発明のリン脂質は、例えば以下のようにして製造することができる。
<無機塩類などを用いてリン脂質中に残存するホスホリパーゼA2を低減するリン脂質の製造方法>
(リゾリン脂質と脂肪酸とのエステル化反応)
ホスホリパーゼA2を触媒としてリゾリン脂質に脂肪酸を結合させることができる反応系であれば方法は問わないが、反応性が高く食品に利用可能なことから、グリセリンを溶剤に用いた反応系で行うが好ましい。即ち、グリセリン中にリゾリン脂質、脂肪酸、ホスホリパーゼA2を適量添加し、反応溶液を30〜60℃に維持しながら、3〜48時間攪拌することで反応を行うことができる。反応系にはさらに、反応を活性化させるための塩化カルシウムなどのカルシウム塩、及びその他アミノ酸等の反応を活性化するための添加物を加えることが好ましい。
The phospholipid of the present invention can be produced, for example, as follows.
<Phospholipid production method for reducing phospholipase A2 remaining in phospholipids using inorganic salts>
(Esterification reaction between lysophospholipid and fatty acid)
Any reaction system can be used as long as it can bind a fatty acid to lysophospholipid using phospholipase A2 as a catalyst. However, since it is highly reactive and can be used in foods, it is preferably carried out in a reaction system using glycerin as a solvent. . That is, the reaction can be carried out by adding appropriate amounts of lysophospholipid, fatty acid and phospholipase A2 to glycerin and stirring for 3 to 48 hours while maintaining the reaction solution at 30 to 60 ° C. It is preferable to add an additive for activating the reaction such as a calcium salt such as calcium chloride for activating the reaction, and other amino acids, to the reaction system.

(リン脂質が生成した反応溶液からのホスホリパーゼA2の除去)
上記リゾリン脂質と脂肪酸とのエステル化反応で得られるリン脂質を含む反応溶液、該反応溶液から単離したリン脂質及び該反応溶液からリン脂質を抽出した溶液の何れかに、炭素数4以下のアルコール及び無機塩類のグリセリン混合溶液、さらにはグリセリンと混和せずリン脂質を溶解する有機溶剤を添加・混合する。なお、それらの添加量は、反応溶液や抽出溶液に当該溶剤を含む場合は適宜調整する。
(Removal of phospholipase A2 from the reaction solution in which phospholipids were generated)
The reaction solution containing the phospholipid obtained by the esterification reaction of the lysophospholipid and the fatty acid, the phospholipid isolated from the reaction solution, and the solution obtained by extracting the phospholipid from the reaction solution have 4 or less carbon atoms. Addition and mixing of glycerin mixed solution of alcohol and inorganic salt, and organic solvent that dissolves phospholipid without being mixed with glycerin. In addition, those addition amounts are appropriately adjusted when the reaction solution or the extraction solution contains the solvent.

そして混合後、20〜60℃に温調し、非極性溶剤とグリセリンが分離しないように強く攪拌する。好ましくは、40〜60℃に温調する。その後しばらく静置して、グリセリン溶液層と溶剤層とを形成させ、リン脂質と脂肪酸が移行した当該溶剤層を分離(分取)する。このような所定溶剤の添加および分取操作は、純度の向上と作業効率を考慮し、適宜繰り返しても良い。   And after mixing, it heat-controls to 20-60 degreeC, and stirs strongly so that a nonpolar solvent and glycerol may not isolate | separate. Preferably, the temperature is adjusted to 40 to 60 ° C. Then, the mixture is allowed to stand for a while to form a glycerin solution layer and a solvent layer, and the solvent layer to which phospholipids and fatty acids have been transferred is separated (sorted). Such addition and preparative operation of the predetermined solvent may be repeated as appropriate in consideration of improvement in purity and work efficiency.

リン脂質もしくはリン脂質と脂肪酸が移行した前記溶剤層を分離したら、溶剤を留去してリン脂質を回収できる。溶剤を留去した後、リン脂質を溶解せず脂肪酸や水を溶解する溶剤で洗浄処理を行い、沈澱したリン脂質を回収する方が好ましい。ここで、リン脂質を溶解せず脂肪酸や水を溶解する溶剤としてはアセトンなどが挙げられる。   When the solvent layer from which phospholipids or phospholipids and fatty acids have migrated is separated, the solvent can be distilled off to recover the phospholipids. After distilling off the solvent, it is preferable to recover the precipitated phospholipid by washing with a solvent that dissolves the fatty acid and water without dissolving the phospholipid. Here, acetone etc. are mentioned as a solvent which does not melt | dissolve a phospholipid but dissolves a fatty acid and water.

ここで前記炭素数4以下のアルコールとしては、メタノール、エタノール、プロパノール及びブタノールが挙げられ、それらの群より選ばれる少なくとも1種を用いることができる。それらの内、毒性が低く食品添加物として利用できることから、エタノールが好ましい。   Here, examples of the alcohol having 4 or less carbon atoms include methanol, ethanol, propanol and butanol, and at least one selected from the group can be used. Of these, ethanol is preferred because it has low toxicity and can be used as a food additive.

また、無機塩類としてはグリセリンへの溶解性があるものなら特に限定は無いが、塩化マグネシウム、硫酸マグネシウム、硫酸亜鉛、塩化カリウム、塩化ナトリウム及び塩化カルシウムからなる群より選ばれる少なくとも1種を使用することが好ましい。無機塩類は、グリセリン混合溶液全体中0.2重量%以上となるように混合して用いることが好ましい。0.2重量%部より少ないとPLA2の除去が十分でない場合がある。無機塩類の濃度は濃いほどPLA2の除去効率は高くなるが、一般にはグリセリン混合溶液全体中40重量%以下とすることが好ましい。40重量%を超えるとグリセリンの粘度が上昇し、もしくは無機塩類が析出して扱いにくくなる場合がある。   The inorganic salt is not particularly limited as long as it is soluble in glycerin, but at least one selected from the group consisting of magnesium chloride, magnesium sulfate, zinc sulfate, potassium chloride, sodium chloride and calcium chloride is used. It is preferable. The inorganic salts are preferably mixed and used so as to be 0.2% by weight or more in the whole glycerin mixed solution. If the amount is less than 0.2% by weight, PLA2 may not be sufficiently removed. The higher the concentration of inorganic salts, the higher the PLA2 removal efficiency. If it exceeds 40% by weight, the viscosity of glycerin may increase, or inorganic salts may precipitate and become difficult to handle.

ここで無機塩類のグリセリン混合溶液の調製は、グリセリンへの塩類の分散性を考慮して、無機塩類を水溶液にしてからグリセリンと混合することが好ましい。さらに、無機塩類を混合したグリセリン混合溶液全体中の水分量は少ないほど好ましいが、30重量%以下であることが好ましく、10重量%以下であることがより好ましく、さらに好ましくは1重量%以下である。グリセリン中の水分量が30重量%を超えると、PLA2の除去が十分に行えない場合がある。また、無機塩類を水溶液にしてからグリセリン混合溶液を調整した場合は、混合溶液中の水を留去してから用いることが好ましい。   Here, the preparation of the glycerin mixed solution of inorganic salts is preferably carried out after mixing the inorganic salts with an aqueous solution in consideration of the dispersibility of the salts in glycerin. Furthermore, the smaller the amount of water in the glycerin mixed solution mixed with inorganic salts, the better, but it is preferably 30% by weight or less, more preferably 10% by weight or less, and even more preferably 1% by weight or less. is there. If the amount of water in glycerin exceeds 30% by weight, PLA2 may not be sufficiently removed. Moreover, when adjusting the glycerol mixed solution after making inorganic salt into aqueous solution, it is preferable to use, after distilling off the water in a mixed solution.

グリセリンと混和せずリン脂質を溶解する有機溶剤としては、炭化水素溶剤やエーテル類が好ましく、具体的にはヘプタン、ヘキサン、ペンタン、ジエチルエーテル、ジイソプロピルエーテル等が挙げられ、食品用途への利用の観点からヘキサンがより好ましい。   As an organic solvent that dissolves phospholipids without being mixed with glycerin, hydrocarbon solvents and ethers are preferable, and specific examples include heptane, hexane, pentane, diethyl ether, diisopropyl ether, and the like. Hexane is more preferable from the viewpoint.

<酸性プロテアーゼを用いてリン脂質中に残存するホスホリパーゼA2の活性を低減するリン脂質の製造方法>
(リゾリン脂質と脂肪酸とのエステル化反応)
前記無機塩類などを用いてリン脂質中に残存するホスホリパーゼA2を低減するリン脂質の製造方法と同様である。
<Method for Producing Phospholipid that Reduces Activity of Phospholipase A2 Remaining in Phospholipid Using Acid Protease>
(Esterification reaction between lysophospholipid and fatty acid)
This is the same as the phospholipid production method for reducing phospholipase A2 remaining in the phospholipid using the inorganic salts.

(リン脂質が生成した反応溶液中のホスホリパーゼA2活性の低減)
上記で得られるリン脂質を、好ましくはpH4.0〜1.0、より好ましくは3.0〜1.5に調整した酸性水溶液に溶解し、酸性プロテアーゼを添加する。酸性プロテアーゼとしては、動物由来のペプシン、Aspergillus niger由来のプロテアーゼ等が挙げられる。酸性プロテアーゼの添加量は、酸性水溶液100重量部に対して0.1〜10重量部が好ましい。
(Reduction of phospholipase A2 activity in the reaction solution in which phospholipids are produced)
The phospholipid obtained above is dissolved in an acidic aqueous solution preferably adjusted to pH 4.0 to 1.0, more preferably 3.0 to 1.5, and acidic protease is added. Examples of acidic proteases include animal-derived pepsin and Aspergillus niger-derived protease. The addition amount of the acidic protease is preferably 0.1 to 10 parts by weight with respect to 100 parts by weight of the acidic aqueous solution.

酸性プロテアーゼを添加した後は、酵素の至適温度で構わないがリン脂質の劣化を防ぐため60℃を上回らない温度に保持して撹拌して酵素反応することが好ましい。反応時間は、酵素の量や反応温度にもよるが、1時間〜48時間が好ましい。1時間より短いと、得られるリン脂質中のホスホリパーゼA2活性低減効果が小さい場合があり、48時間より長いと、リン脂質が劣化する、もしくはリン脂質が凝集したり、プロテアーゼが失活するなどして得られるリン脂質中のホスホリパーゼA2活性低減効果が頭を打ってしまう場合がある。   After the addition of the acidic protease, the optimal temperature of the enzyme may be used, but it is preferable to carry out the enzyme reaction by stirring and maintaining at a temperature not exceeding 60 ° C. in order to prevent deterioration of the phospholipid. The reaction time depends on the amount of enzyme and reaction temperature, but is preferably 1 hour to 48 hours. If it is shorter than 1 hour, the phospholipase A2 activity reducing effect in the obtained phospholipid may be small. If it is longer than 48 hours, the phospholipid deteriorates, or the phospholipid aggregates or the protease is inactivated. The phospholipase A2 activity-reducing effect in the phospholipid obtained in this way may hit the head.

ホスホリパーゼA2活性をさらに低減するためには、酸性プロテアーゼ反応終了後、続けてpHを4.0〜8.0に中和し、中性プロテアーゼを添加することが好ましく、より好ましくはpHを5.0〜7.0に中和し、中性プロテアーゼを添加する。中性プロテアーゼとしてはAspergillus Oryzae由来、Bacillus Subtilis由来等が挙げられる。   In order to further reduce the phospholipase A2 activity, it is preferable to neutralize the pH to 4.0 to 8.0 after completion of the acidic protease reaction and add a neutral protease, more preferably 5. Neutralize to 0-7.0 and add neutral protease. Examples of neutral protease include those derived from Aspergillus Oryzae and Bacillus Subtilis.

中性プロテアーゼを添加した後は、酵素の至適温度で構わないがリン脂質の劣化を防ぐため60℃を上回らない温度に保持して撹拌して酵素反応することが好ましい。反応時間は、酵素の量や反応温度にもよるが、1時間〜48時間が好ましい。1時間より短いと、得られるリン脂質中のホスホリパーゼA2活性低減効果が小さい場合があり、48時間より長いと、リン脂質が劣化する、もしくはリン脂質が凝集したり、プロテアーゼが失活するなどして得られるリン脂質中のホスホリパーゼA2活性低減効果が頭を打ってしまう場合がある。   After adding the neutral protease, the optimal temperature of the enzyme may be used, but it is preferable to carry out the enzyme reaction by stirring and maintaining at a temperature not exceeding 60 ° C. in order to prevent phospholipid degradation. The reaction time depends on the amount of enzyme and reaction temperature, but is preferably 1 hour to 48 hours. If it is shorter than 1 hour, the phospholipase A2 activity reducing effect in the obtained phospholipid may be small. If it is longer than 48 hours, the phospholipid deteriorates, or the phospholipid aggregates or the protease is inactivated. The phospholipase A2 activity-reducing effect in the phospholipid obtained in this way may hit the head.

酸性プロテアーゼ或いは酸性プロテアーゼ及び中性プロテアーゼによる酵素反応終了後は、ヘキサン等のリン脂質を溶解し、水と混和しない溶剤を酸性水溶液100重量部に対して10〜200重量部添加・撹拌し、上層(ヘキサン層)を分取し、上層の溶剤を除去してリン脂質を抽出することができる。酸性水溶液の粘度が高くなるなどして、ヘキサンだけではリン脂質を抽出しにくい場合は、さらにエタノールなどの、水と混和するアルコール溶剤を加えることで抽出効率が向上する場合がある。エタノールを加える場合は、酸性水溶液100重量部に対して10〜100重量部加えるのが好ましい。この処理により得られるリン脂質中のホスホリパーゼA2活性は、大幅に低減されている。   After completion of the enzymatic reaction with acidic protease or acidic protease and neutral protease, phospholipid such as hexane is dissolved, 10 to 200 parts by weight of a solvent immiscible with water is added to 100 parts by weight of acidic aqueous solution and stirred, and the upper layer (Hexane layer) is collected, and the phospholipid can be extracted by removing the solvent in the upper layer. If it is difficult to extract phospholipids with hexane alone due to an increase in the viscosity of the acidic aqueous solution, the extraction efficiency may be improved by adding an alcohol solvent miscible with water such as ethanol. When adding ethanol, it is preferable to add 10-100 weight part with respect to 100 weight part of acidic aqueous solution. The phospholipase A2 activity in the phospholipid obtained by this treatment is greatly reduced.

前記において、上層の溶剤を除去した後、アセトンで洗浄する方が好ましい。アセトン洗浄により、残留している水分や加水分解で遊離した脂肪酸などを除去することができる。   In the above, it is preferable to wash with acetone after removing the solvent of the upper layer. By washing with acetone, residual water, fatty acids released by hydrolysis, and the like can be removed.

本発明のリン脂質の製造方法は、食用や飼料用のリン脂質の製造に好適に用いることができ、その為には製造過程で食用に適さない原料やトルエン、ホルムアミドなどの溶剤などを使用さえしなければよい。また、このようにして得られたリン脂質、特に、その2位に高度不飽和脂肪酸が導入されたものは、高機能の食用或いは飼料用リン脂質として好適に用いることができる。   The method for producing phospholipids of the present invention can be suitably used for the production of phospholipids for food and feed. For this purpose, even raw materials that are not suitable for food and solvents such as toluene and formamide are used in the production process. If you don't. In addition, the phospholipid thus obtained, particularly one having a highly unsaturated fatty acid introduced at the 2-position thereof, can be suitably used as a highly functional edible or feed phospholipid.

以下に実施例を示し、本発明をより具体的に説明するが、本発明はこれらの実施例に何ら限定されるものではない。なお、実施例において「部」や「%」は重量基準である。   EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. However, the present invention is not limited to these examples. In the examples, “parts” and “%” are based on weight.

<PLA2の残存活性の測定方法>
脱脂大豆レシチン6gに蒸留水400mlを加えて室温で30分間攪拌した。その脱脂大豆レシチン溶液に、デオキシコール酸ナトリウム0.7g及び塩化カルシウム2水和物0.5gを水11mlに溶かした溶液を加え、氷冷しながら8000rpmで15分間ホモジナイズした。得られた溶液を活性測定溶液とした。活性測定溶液20mlを50mlのサンプル瓶に計り取り、1M水酸化ナトリウム水溶液を加えてpHを8.0に調整した。実施例・比較例で得られたリン脂質サンプル20mgを1mlの蒸留水に分散させ、その溶液をpH8.0に調整した活性測定溶液に加えて、再度pHを8.0に調整し、pHを8.0に維持するために必要な20mM水酸化ナトリウム溶液の1分当たりの滴定量を測定した。あらかじめ酵素標準溶液で作成した検量線を用いて、リン脂質に残存するPLA2活性を計算した。
<Method for measuring residual activity of PLA2>
400 ml of distilled water was added to 6 g of defatted soybean lecithin and stirred at room temperature for 30 minutes. A solution prepared by dissolving 0.7 g of sodium deoxycholate and 0.5 g of calcium chloride dihydrate in 11 ml of water was added to the defatted soybean lecithin solution, and homogenized at 8000 rpm for 15 minutes while cooling with ice. The obtained solution was used as an activity measurement solution. 20 ml of the activity measurement solution was weighed into a 50 ml sample bottle, and 1M sodium hydroxide aqueous solution was added to adjust the pH to 8.0. Disperse 20 mg of the phospholipid sample obtained in Examples and Comparative Examples in 1 ml of distilled water, add the solution to the activity measurement solution adjusted to pH 8.0, adjust the pH to 8.0 again, and adjust the pH to The titer per minute of 20 mM sodium hydroxide solution required to maintain 8.0 was measured. The PLA2 activity remaining in the phospholipid was calculated using a calibration curve prepared in advance with an enzyme standard solution.

<リン脂質の脂肪酸組成の分析>
実施例・比較例で得られたリン脂質10mgをイソオクタン2mlに溶かし、0.2Mナトリウムメチラートのメタノール溶液1mlを加えて60℃で攪拌しながら10分間加熱した。酢酸で中和し、水を加えて上層のイソオクタン層を回収してガスクロマトグラフで分析した。ガスクロマトグラフはアジレント社製「5890seriesII」を使用した。カラムは、アジレント社製「DB−23」(長さ30m、内径0.25mm、膜厚0.25μm)を用いて、注入口温度:260℃、検出温度:260℃、オーブン温度:200℃一定で行った。
<Analysis of fatty acid composition of phospholipid>
10 mg of the phospholipid obtained in Examples and Comparative Examples was dissolved in 2 ml of isooctane, 1 ml of a methanol solution of 0.2 M sodium methylate was added, and the mixture was heated at 60 ° C. with stirring for 10 minutes. The mixture was neutralized with acetic acid, water was added, and the upper isooctane layer was recovered and analyzed by gas chromatography. As the gas chromatograph, “5890 series II” manufactured by Agilent was used. The column was “DB-23” (length 30 m, inner diameter 0.25 mm, film thickness 0.25 μm) manufactured by Agilent, inlet temperature: 260 ° C., detection temperature: 260 ° C., oven temperature: constant 200 ° C. I went there.

(製造例1) リン脂質の合成
1Lのガラス製反応容器にグリセリン(坂本薬品社製)200gにリゾホスファチジルコリン(辻製油社製「SLP−ホワイトリゾ」)15g、ホスホリパーゼA2(サンヨーファイン社製「リゾナーゼ」、活性:5万U/g)6g、DHA含有トリグリセリド(クローダジャパン「インクロメガDHA−J46」、DHA含有量:49.7重量%)を定法によりアルカリ加水分解した脂肪酸6g、グリシン6g、アラニン6g、2M塩化カルシウム水溶液2mlを加えて攪拌しながら300Paの減圧下、50℃で24時間反応させた。反応終了後、エタノール100ml、ヘキサン100mlを加えて二層にした。ここから上層を回収し、溶剤を留去した回収物を15g得た。該回収物にアセトン50mlを加えてよくかき混ぜ、0℃で1時間冷却して得られた沈澱を回収し、リン脂質を10g得た。このリン脂質中に残存するPLA2の活性は、75U/gであった。また、リン脂質中の脂肪酸組成のうち、DHAの含量は16.5重量%だった。
(Production Example 1) Synthesis of Phospholipid In a 1 L glass reaction vessel, 200 g of glycerin (manufactured by Sakamoto Pharmaceutical Co., Ltd.), 15 g of lysophosphatidylcholine (“SLP-white lyso” manufactured by Sakai Oil Co., Ltd.), phospholipase A2 (manufactured by Sanyo Fine Co., Ltd. ”, Activity: 50,000 U / g), 6 g of DHA-containing triglyceride (Croda Japan“ Incromega DHA-J46 ”, DHA content: 49.7% by weight) by alkaline hydrolysis according to a conventional method 6 g of fatty acid, 6 g of glycine, 6 g of alanine 2 ml of 2M calcium chloride aqueous solution was added and reacted at 50 ° C. for 24 hours under reduced pressure of 300 Pa while stirring. After completion of the reaction, 100 ml of ethanol and 100 ml of hexane were added to form two layers. From this, the upper layer was recovered, and 15 g of a recovered product obtained by removing the solvent was obtained. To the recovered product, 50 ml of acetone was added and mixed well, and the precipitate obtained by cooling at 0 ° C. for 1 hour was recovered to obtain 10 g of phospholipid. The activity of PLA2 remaining in this phospholipid was 75 U / g. Of the fatty acid composition in the phospholipid, the DHA content was 16.5% by weight.

(実施例1) 無機塩類などによる処理によるPLA2低減
リン脂質0.2gにグリセリン1gを加え、2M塩化カルシウム水溶液を0.4ml加えて、グリセリン溶液を調整した。ヘキサン1mlとエタノール1mlを加えて室温で1時間攪拌した。攪拌終了後、静置してから上層を回収し、溶剤を留去後、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Example 1) PLA2 reduction by treatment with inorganic salts, etc. 1 g of glycerin was added to 0.2 g of phospholipid, and 0.4 ml of 2M calcium chloride aqueous solution was added to prepare a glycerin solution. 1 ml of hexane and 1 ml of ethanol were added and stirred at room temperature for 1 hour. After completion of stirring, the mixture was allowed to stand and then the upper layer was collected. After the solvent was distilled off, 1 ml of acetone was added and the mixture was allowed to stand at 0 ° C. for 1 hour to collect a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

Figure 2012249597
Figure 2012249597

Figure 2012249597
Figure 2012249597

(実施例2) 無機塩類などによる処理によるPLA2低減
50℃で1時間攪拌した以外は、実施例1と同様にしてリン脂質を処理した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Example 2) PLA2 reduction by treatment with inorganic salts and the like Phospholipids were treated in the same manner as in Example 1 except that the mixture was stirred at 50 ° C for 1 hour. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(実施例3)
グリセリン5gに2M塩化カルシウム水溶液2mlを加えた。このグリセリン溶液を80℃、500Paで1時間乾燥させた。リン脂質サンプル0.2gをヘキサン1mlとエタノール1mlの混合溶媒に溶かし、上記で作製した塩化カルシウム−グリセリン溶液1gを加えて室温で1時間層分離しないように強く攪拌した。攪拌終了後、静置して上層を回収し溶剤を留去して、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Example 3)
2 ml of 2M calcium chloride aqueous solution was added to 5 g of glycerin. This glycerin solution was dried at 80 ° C. and 500 Pa for 1 hour. A phospholipid sample (0.2 g) was dissolved in a mixed solvent of 1 ml of hexane and 1 ml of ethanol, and 1 g of the calcium chloride-glycerin solution prepared above was added, and the mixture was vigorously stirred so as not to separate the layers at room temperature for 1 hour. After completion of the stirring, the mixture was allowed to stand to recover the upper layer, the solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(実施例4)
50℃で1時間攪拌した以外は、実施例3と同様にリン脂質サンプルを処理し、リン脂質を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
Example 4
The phospholipid sample was treated in the same manner as in Example 3 except that the mixture was stirred at 50 ° C. for 1 hour, and the phospholipid was recovered. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(実施例5)
実施例4と同様に1時間攪拌した後、上層を回収して溶剤を留去し、さらにヘキサンを加えて沈澱したグリセリンを除去した。溶剤を留去して、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Example 5)
After stirring for 1 hour in the same manner as in Example 4, the upper layer was recovered, the solvent was distilled off, and further hexane was added to remove the precipitated glycerin. The solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(実施例6)
2M塩化カルシウム水溶液の代わりに2M塩化カリウム水溶液を用いた以外は、実施例5と同様にリン脂質を処理した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Example 6)
The phospholipid was treated in the same manner as in Example 5 except that 2M potassium chloride aqueous solution was used instead of 2M calcium chloride aqueous solution. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(実施例7)
2M塩化カルシウム水溶液の代わりに2M塩化ナトリウム水溶液を用いた以外は、実施例5と同様に処理した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Example 7)
The treatment was performed in the same manner as in Example 5 except that a 2M sodium chloride aqueous solution was used instead of the 2M calcium chloride aqueous solution. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(実施例8)
2M塩化カルシウム水溶液の代わりに2M硫酸マグネシウム水溶液を用い、エタノールの代わりにイソプロパーノールを用い、50℃で1時間攪拌した以外は、実施例3と同様にしてリン脂質サンプルを処理し、リン脂質を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Example 8)
A phospholipid sample was treated in the same manner as in Example 3 except that 2M magnesium sulfate aqueous solution was used instead of 2M calcium chloride aqueous solution, isopropanol was used instead of ethanol and stirred at 50 ° C. for 1 hour. Was recovered. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(実施例9)
2M塩化カルシウム水溶液の代わりに2M塩化マグネシウム水溶液を用い、ヘキサンの代わりにジエチルエーテルを用いた以外は、実施例3と同様にしてリン脂質サンプルを処理し、リン脂質を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
Example 9
Phospholipid samples were treated and phospholipids were recovered in the same manner as in Example 3 except that 2M magnesium chloride aqueous solution was used instead of 2M calcium chloride aqueous solution and diethyl ether was used instead of hexane. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(比較例1)
リン脂質サンプル0.2gにグリセリン1gを加え、ヘキサン1mlとエタノール1mlを加えて50℃で1時間攪拌した。攪拌終了後、静置して上層を回収し溶剤を留去して、アセトン1mlを加えて50℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Comparative Example 1)
1 g of glycerin was added to 0.2 g of a phospholipid sample, 1 ml of hexane and 1 ml of ethanol were added, and the mixture was stirred at 50 ° C. for 1 hour. After completion of the stirring, the mixture was allowed to stand to recover the upper layer, the solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 50 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(比較例2)
国際公開第05/090587号に準拠して、リン脂質サンプル0.2gをヘキサン1mlとエタノール1mlに溶かし、2.6M塩化ナトリウム水溶液(水1ml、塩化ナトリウム150mg)を1ml加えて50℃で1時間攪拌した。攪拌終了後、静置して上層を回収し溶剤を留去して、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Comparative Example 2)
In accordance with International Publication No. 05/090587, 0.2 g of phospholipid sample was dissolved in 1 ml of hexane and 1 ml of ethanol, and 1 ml of 2.6 M sodium chloride aqueous solution (water 1 ml, sodium chloride 150 mg) was added for 1 hour at 50 ° C. Stir. After completion of the stirring, the mixture was allowed to stand to recover the upper layer, the solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(比較例3)
国際公開第05/090587号に準拠して、リン脂質サンプル0.2gをヘキサン1mlとアセトン1mlに溶かし、2.6M塩化ナトリウム水溶液(水1ml、塩化ナトリウム150mg)を1ml加えて50℃で1時間攪拌した。攪拌終了後、静置して上層を回収し溶剤を留去して、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Comparative Example 3)
In accordance with International Publication No. 05/090587, 0.2 g of a phospholipid sample is dissolved in 1 ml of hexane and 1 ml of acetone, and 1 ml of 2.6 M sodium chloride aqueous solution (water 1 ml, sodium chloride 150 mg) is added at 50 ° C. for 1 hour. Stir. After completion of the stirring, the mixture was allowed to stand to recover the upper layer, the solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(比較例4)
グリセリン5gに2M塩化カルシウム水溶液2mlを加えた。このグリセリン溶液を80℃、500Paで1時間乾燥させた。リン脂質サンプル0.2gをヘキサン1mlに溶かし、上記で作製した塩化カリウム−グリセリン溶液1gを加えて50℃で1時間層分離しないように強く攪拌した。攪拌終了後、静置して上層を回収し溶剤を留去した。溶剤を留去し、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Comparative Example 4)
2 ml of 2M calcium chloride aqueous solution was added to 5 g of glycerin. This glycerin solution was dried at 80 ° C. and 500 Pa for 1 hour. A phospholipid sample (0.2 g) was dissolved in hexane (1 ml), the potassium chloride-glycerin solution (1 g) prepared above was added, and the mixture was vigorously stirred at 50 ° C. for 1 hour so as not to separate the layers. After completion of the stirring, the mixture was allowed to stand to recover the upper layer, and the solvent was distilled off. The solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(比較例5)
グリセリン5gに2M塩化カルシウム水溶液2mlを加えた。このグリセリン溶液を80℃、500Paで1時間乾燥させた。リン脂質サンプル0.2gをジエチルエーテル1mlに溶かし、上記で作製した塩化カリウム−グリセリン溶液1gを加えて室温で1時間層分離しないように強く攪拌した。攪拌終了後、静置して上層を回収し溶剤を留去した。溶剤を留去し、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Comparative Example 5)
2 ml of 2M calcium chloride aqueous solution was added to 5 g of glycerin. This glycerin solution was dried at 80 ° C. and 500 Pa for 1 hour. A phospholipid sample (0.2 g) was dissolved in 1 ml of diethyl ether, 1 g of the potassium chloride-glycerin solution prepared above was added, and the mixture was vigorously stirred so as not to separate the layers at room temperature for 1 hour. After completion of the stirring, the mixture was allowed to stand to recover the upper layer, and the solvent was distilled off. The solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(比較例6)
グリセリン5gに2M硫酸マグネシウム水溶液2mlを加えた。このグリセリン溶液を80℃、500Paで1時間乾燥させた。リン脂質サンプル0.2gをヘキサン1mlとアセトン1mlの混合溶媒に溶かし、上記で作製した硫酸マグネシウム−グリセリン溶液1gを加えて50℃で1時間層分離しないように強く攪拌した。攪拌終了後、静置して上層を回収し溶剤を留去した。溶剤を留去し、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Comparative Example 6)
2 ml of 2M aqueous magnesium sulfate solution was added to 5 g of glycerin. This glycerin solution was dried at 80 ° C. and 500 Pa for 1 hour. A 0.2 g phospholipid sample was dissolved in a mixed solvent of 1 ml of hexane and 1 ml of acetone, 1 g of the magnesium sulfate-glycerin solution prepared above was added, and the mixture was vigorously stirred so as not to separate the layers at 50 ° C. for 1 hour. After completion of the stirring, the mixture was allowed to stand to recover the upper layer, and the solvent was distilled off. The solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(比較例7)
公開広報2002−165580号公報に準拠して、リン脂質サンプル0.2gに水2mlを加えて80℃で90分攪拌しながら加熱した。攪拌終了後、ヘキサンを2ml加えて1分間撹拌してから静置して上層を回収した。溶剤を留去し、アセトン1mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性、およびリン脂質の脂肪酸組成中のDHA含量を表1に示した。
(Comparative Example 7)
In accordance with Japanese Patent Publication No. 2002-165580, 2 ml of water was added to 0.2 g of a phospholipid sample and heated at 80 ° C. with stirring for 90 minutes. After completion of the stirring, 2 ml of hexane was added and stirred for 1 minute, and then allowed to stand to recover the upper layer. The solvent was distilled off, 1 ml of acetone was added, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. Table 1 shows the PLA2 residual activity in the collected phospholipid and the DHA content in the fatty acid composition of the phospholipid.

(実施例10) 酵素処理によるPLA2低減
製造例1で得たリン脂質1gを0.2Mクエン酸水溶液10mlに分散させ、pH2.4とした。この水溶液に酸性プロテアーゼ(エイチビイアイ社製「オリエンターゼ20A」)120mgを加えて45℃で5時間攪拌した。攪拌終了後反応液にエタノール5mlとヘキサン5mlを加えて攪拌してから静置して上層(ヘキサン層)を回収した。上層の溶剤を留去し、残渣にアセトン5mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性は4U/g、リン脂質の脂肪酸組成中のDHA含量は16.9重量%であった。
(Example 10) PLA2 reduction by enzyme treatment 1 g of the phospholipid obtained in Production Example 1 was dispersed in 10 ml of 0.2 M aqueous citric acid solution to a pH of 2.4. To this aqueous solution, 120 mg of acidic protease (“Orientase 20A” manufactured by HIBI) was added and stirred at 45 ° C. for 5 hours. After completion of the stirring, 5 ml of ethanol and 5 ml of hexane were added to the reaction solution, stirred and allowed to stand to recover the upper layer (hexane layer). The solvent in the upper layer was distilled off, 5 ml of acetone was added to the residue, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. The residual activity of PLA2 in the recovered phospholipid was 4 U / g, and the DHA content in the fatty acid composition of the phospholipid was 16.9% by weight.

(実施例11) 酵素処理によるPLA2低減
リン脂質サンプル1gを0.2Mクエン酸水溶液10mlに分散させ、pH2.4とした。この水溶液に酸性プロテアーゼ(エイチビイアイ社製「オリエンターゼ20A」)120mgを加えて45℃で5時間攪拌した。攪拌終了後反応液に1M水酸化ナトリウム水溶液を添加してpH7.0に調整し、中性プロテアーゼ(アマノエンザイム社製「ペプチダーゼR」)120mgを加えて45℃で3時間攪拌した。攪拌終了後反応液にエタノール5mlとヘキサン5mlを加えて攪拌してから静置して上層を回収した。上層の溶剤を留去し、残渣にアセトン5mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性は1U/g以下、リン脂質の脂肪酸組成中のDHA含量は17.1重量%であった。
(Example 11) PLA2 reduction by enzyme treatment 1 g of a phospholipid sample was dispersed in 10 ml of a 0.2 M aqueous citric acid solution to a pH of 2.4. To this aqueous solution, 120 mg of acidic protease (“Orientase 20A” manufactured by HIBI) was added and stirred at 45 ° C. for 5 hours. After completion of the stirring, 1M sodium hydroxide aqueous solution was added to the reaction solution to adjust the pH to 7.0, 120 mg of neutral protease (“Peptidase R” manufactured by Amano Enzyme) was added, and the mixture was stirred at 45 ° C. for 3 hours. After completion of the stirring, 5 ml of ethanol and 5 ml of hexane were added to the reaction solution, stirred and allowed to stand to recover the upper layer. The solvent in the upper layer was distilled off, 5 ml of acetone was added to the residue, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. The residual activity of PLA2 in the collected phospholipid was 1 U / g or less, and the DHA content in the fatty acid composition of the phospholipid was 17.1% by weight.

(比較例8) 酵素処理によるPLA2低減
リン脂質サンプル1gを水10mlに分散させ、プロテアーゼ(アマノエンザイム社製「ペプチダーゼR」)120mgを加えて45℃で5時間攪拌した。攪拌終了後、反応液にエタノール5mlとヘキサン5mlを加えて1分間攪拌してから静置して上層を回収した。上層の溶剤を留去し、残渣にアセトン5mlを加えて0℃で1時間静置し、リン脂質の沈澱を回収した。回収したリン脂質中のPLA2残存活性は15U/g、リン脂質の脂肪酸組成中のDHA含量は10.5重量%であった。
(Comparative Example 8) PLA2 reduction by enzyme treatment 1 g of a phospholipid sample was dispersed in 10 ml of water, 120 mg of protease (“Peptidase R” manufactured by Amano Enzyme) was added, and the mixture was stirred at 45 ° C. for 5 hours. After the completion of stirring, 5 ml of ethanol and 5 ml of hexane were added to the reaction solution, stirred for 1 minute, and allowed to stand to recover the upper layer. The solvent in the upper layer was distilled off, 5 ml of acetone was added to the residue, and the mixture was allowed to stand at 0 ° C. for 1 hour to recover a phospholipid precipitate. The residual activity of PLA2 in the collected phospholipid was 15 U / g, and the DHA content in the fatty acid composition of the phospholipid was 10.5% by weight.

Claims (13)

ホスホリパーゼA2による脂肪酸とリゾリン脂質のエステル化反応により得られるリン脂質であり、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質。 A phospholipid obtained by esterification of a fatty acid and lysophospholipid with phospholipase A2 and having a remaining phospholipase A2 activity of 10 units / g or less. 残存するホスホリパーゼA2活性が5ユニット/g以下である請求項1に記載のリン脂質。 The phospholipid according to claim 1, wherein the remaining phospholipase A2 activity is 5 units / g or less. リン脂質の構成脂肪酸全体中、二重結合を4つ以上持つ脂肪酸及び共役した2つ以上の二重結合を持つ脂肪酸の合計量が、15重量%以上である請求項1又は2に記載のリン脂質。 The phosphorus according to claim 1 or 2, wherein the total amount of fatty acids having 4 or more double bonds and fatty acids having 2 or more conjugated double bonds in the total fatty acids of the phospholipid is 15% by weight or more. Lipids. ホスホリパーゼA2による脂肪酸とリゾリン脂質のエステル化反応により得られるリン脂質に、無機塩類のグリセリン溶液及び炭素数4以下のアルコール、さらにはグリセリンと混和せずリン脂質を溶解する有機溶剤を添加し、充分に撹拌した後静置し、該有機溶剤層を抽出することを特徴とする、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 To the phospholipid obtained by esterification of fatty acid and lysophospholipid with phospholipase A2, add a glycerin solution of inorganic salts and an alcohol having 4 or less carbon atoms, and an organic solvent that is immiscible with glycerin and dissolves the phospholipid. A method for producing a phospholipid having a residual phospholipase A2 activity of 10 units / g or less, wherein the organic solvent layer is extracted after stirring. 無機塩類のグリセリン混合溶液中の水分量が10重量%以下である、請求項4に記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 The method for producing a phospholipid according to claim 4, wherein the amount of water in the glycerin mixed solution of inorganic salts is 10% by weight or less, and the remaining phospholipase A2 activity is 10 units / g or less. グリセリンと混和せずリン脂質を溶解する有機溶剤が、炭素数が5〜8の炭化水素溶剤及び/又はエーテル類である、請求項4又は5に記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 6. The remaining phospholipase A2 activity of 10 units / percent of the organic solvent that dissolves phospholipids without being mixed with glycerin is a hydrocarbon solvent having 5 to 8 carbon atoms and / or ethers. The manufacturing method of the phospholipid which is below g. グリセリン溶液中の塩濃度が、0.2〜40重量%である請求項4〜6の何れかに記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 The method for producing a phospholipid having a residual phospholipase A2 activity of 10 units / g or less according to any one of claims 4 to 6, wherein the salt concentration in the glycerin solution is 0.2 to 40% by weight. 無機塩類が、硫酸亜鉛、塩化カリウム、塩化マグネシウム、硫酸マグネシウム、塩化ナトリウム及び塩化カルシウムの群より選ばれる少なくとも1種である、請求項4〜7の何れかに記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 The remaining phospholipase A2 activity according to any one of claims 4 to 7, wherein the inorganic salt is at least one selected from the group consisting of zinc sulfate, potassium chloride, magnesium chloride, magnesium sulfate, sodium chloride and calcium chloride. A method for producing a phospholipid of 10 units / g or less. 炭化水素溶剤がヘキサンである、請求項4〜8の何れかに記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 The method for producing a phospholipid according to any one of claims 4 to 8, wherein the hydrocarbon solvent is hexane, and the remaining phospholipase A2 activity is 10 units / g or less. 炭素数4以下のアルコールがエタノールである、請求項4〜9の何れかに記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 The method for producing a phospholipid according to any one of claims 4 to 9, wherein the alcohol having 4 or less carbon atoms is ethanol, wherein the remaining phospholipase A2 activity is 10 units / g or less. 撹拌中の温度が40〜60℃である、請求項4〜10の何れかに記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 The manufacturing method of the phospholipid whose residual phospholipase A2 activity is 10 units / g or less in any one of Claims 4-10 whose temperature during stirring is 40-60 degreeC. ホスホリパーゼA2による脂肪酸とリゾリン脂質のエステル化反応により得られるリン脂質反応液を、酸性プロテアーゼで処理することを特徴とする、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 A method for producing a phospholipid having a residual phospholipase A2 activity of 10 units / g or less, characterized by treating a phospholipid reaction solution obtained by esterification of a fatty acid and lysophospholipid with phospholipase A2 with an acidic protease. 酸性プロテアーゼで処理した後、さらに中性プロテアーゼで処理することを特徴とする請求項12に記載の、残存するホスホリパーゼA2活性が10ユニット/g以下であるリン脂質の製造方法。 The method for producing a phospholipid according to claim 12, wherein the remaining phospholipase A2 activity is 10 units / g or less, wherein the phospholipase A2 activity is 10 units / g or less.
JP2011125743A 2011-06-03 2011-06-03 Method for producing phospholipid Active JP5894377B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011125743A JP5894377B2 (en) 2011-06-03 2011-06-03 Method for producing phospholipid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011125743A JP5894377B2 (en) 2011-06-03 2011-06-03 Method for producing phospholipid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015234553A Division JP6177862B2 (en) 2015-12-01 2015-12-01 Method for producing phospholipid

Publications (2)

Publication Number Publication Date
JP2012249597A true JP2012249597A (en) 2012-12-20
JP5894377B2 JP5894377B2 (en) 2016-03-30

Family

ID=47523068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011125743A Active JP5894377B2 (en) 2011-06-03 2011-06-03 Method for producing phospholipid

Country Status (1)

Country Link
JP (1) JP5894377B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013187328A1 (en) * 2012-06-13 2013-12-19 株式会社カネカ Method for producing phospholipid-containing composition, and phospholipid-containing composition
JP2017501998A (en) * 2013-12-05 2017-01-19 エンザイモテック リミティド Serine glycerophospholipid preparation and seizure treatment method

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718995A (en) * 1980-07-10 1982-01-30 Terumo Corp Production of low-molecular-weight peptide composition
JPS58152498A (en) * 1982-03-06 1983-09-10 Terumo Corp Production of low-molecular peptide mixture
JPS63233750A (en) * 1987-03-23 1988-09-29 Q P Corp Production of treated phospholipid
JPS646071A (en) * 1987-06-29 1989-01-10 Mitsubishi Yuka Badische Algicidal coating composition
JPH01269499A (en) * 1988-04-20 1989-10-26 Seiwa Kasei:Kk Production of casein peptide
JP2002193982A (en) * 2000-12-05 2002-07-10 Chemi Spa Method for purifying phosphatidyl serine
WO2005090587A1 (en) * 2004-03-18 2005-09-29 Nagase Chemtex Corporation Method of removing enzyme and method of base exchange or hydrolysis of phospholipid using the same
WO2006134752A1 (en) * 2005-06-15 2006-12-21 Fuji Oil Company, Limited Soybean peptide composition
JP2010068799A (en) * 2008-08-22 2010-04-02 Kaneka Corp Method for producing phospholipid

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718995A (en) * 1980-07-10 1982-01-30 Terumo Corp Production of low-molecular-weight peptide composition
JPS58152498A (en) * 1982-03-06 1983-09-10 Terumo Corp Production of low-molecular peptide mixture
JPS63233750A (en) * 1987-03-23 1988-09-29 Q P Corp Production of treated phospholipid
JPS646071A (en) * 1987-06-29 1989-01-10 Mitsubishi Yuka Badische Algicidal coating composition
JPH01269499A (en) * 1988-04-20 1989-10-26 Seiwa Kasei:Kk Production of casein peptide
JP2002193982A (en) * 2000-12-05 2002-07-10 Chemi Spa Method for purifying phosphatidyl serine
WO2005090587A1 (en) * 2004-03-18 2005-09-29 Nagase Chemtex Corporation Method of removing enzyme and method of base exchange or hydrolysis of phospholipid using the same
WO2006134752A1 (en) * 2005-06-15 2006-12-21 Fuji Oil Company, Limited Soybean peptide composition
JP2010068799A (en) * 2008-08-22 2010-04-02 Kaneka Corp Method for producing phospholipid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013187328A1 (en) * 2012-06-13 2013-12-19 株式会社カネカ Method for producing phospholipid-containing composition, and phospholipid-containing composition
JP5477521B1 (en) * 2012-06-13 2014-04-23 株式会社カネカ Method for producing phospholipid-containing composition and phospholipid-containing composition
US10160984B2 (en) 2012-06-13 2018-12-25 Kaneka Corporation Method for producing phospholipid-containing composition, and phospholipid-containing composition
JP2017501998A (en) * 2013-12-05 2017-01-19 エンザイモテック リミティド Serine glycerophospholipid preparation and seizure treatment method

Also Published As

Publication number Publication date
JP5894377B2 (en) 2016-03-30

Similar Documents

Publication Publication Date Title
JP3905538B2 (en) Methods for reducing environmental pollutants in oil or fat, volatile environmental pollutant reducing working fluids, health supplements and animal feed products
EP0399544B1 (en) Process for the production of phosphatidic acid
JP3853464B2 (en) Production method of plant lysolecithin
JP6026672B2 (en) Removal of unwanted components from oil compositions
TW201210513A (en) Producing method of phospholipids including long-chain polyunsaturated fatty acids as constituents, and use of such phospholipids
EP2453020B1 (en) Method for producing phospholipid
WO2005038037A2 (en) Methods for preparing phospholipids containing omega-3 and omega-6 moieties
CN106459829B (en) Long chain monounsaturated fatty acid compositions and methods of making the same
JP5477521B1 (en) Method for producing phospholipid-containing composition and phospholipid-containing composition
JP5617141B2 (en) Method for producing phospholipid
JP5894377B2 (en) Method for producing phospholipid
JP6177862B2 (en) Method for producing phospholipid
Estiasih et al. Modification of soy crude lecithin by partial enzymatic hydrolysis using phosholipase A1
JP2007209272A (en) Method for producing phospholipid containing long chain highly unsaturated fatty acid produced by microbial fermentation as component
JP2006197842A (en) Composition having phospholipase a1 activity, 2-acyl type lysophospholipid obtained by using the same and method for producing those
JP2001186898A (en) Method for producing phosphatidyl serine having polyvalent unsaturated fatty acid residue
JP5041790B2 (en) Process for producing phosphatidylserine having polyunsaturated fatty acid as a constituent
JP2008125365A (en) Method for preparing high-purity plasmologen
JP6614581B2 (en) Phospholipid type α-linolenic acid-containing composition
JP2021155756A (en) Method for producing marine product-derived free monounsaturated fatty acid or lower alcohol ester thereof
JPH05123176A (en) Production of highly unsaturated fatty acid phospholipid
JP2010159383A (en) Method for separating complex lipid
JP2004283043A (en) Method for producing medium chain fatty acid-bound phospholipid

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150603

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150723

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20150723

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151201

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20151211

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160202

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160226

R150 Certificate of patent or registration of utility model

Ref document number: 5894377

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250